会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • TRIAZOLO COMPOUNDS AS MMP INHIBITORS
    • TRIAZOLO化合物作为MMP抑制剂
    • WO2002064595A1
    • 2002-08-22
    • PCT/EP2002/001961
    • 2002-02-11
    • WARNER-LAMBERT COMPANYANDRIANJARA, CharlesJACOBELLI, HenryGAUDILLIERE, BernardBREUZARD, Francine
    • ANDRIANJARA, CharlesJACOBELLI, HenryGAUDILLIERE, BernardBREUZARD, Francine
    • C07D487/04
    • C07D487/04
    • A compound selected from those of formula (I): in which: W represents N or C-R 1 ; in which R 1 is as defined in the description, X represents N or C-R 2 in which R 2 is as defined in the description, Y represents a group selected from oxygen, sulfur, -NH, and -Nalkyl, Z represents a group selected from oxygen, sulphur, -NR 8 in which R 8 is as defined in the description, and optionally carbon depending the definition of Y, n is an integer from 0 to 8 inclusive, Z 1 represents a group -CR 9 R 10 wherein R 9 and R 10 , are as defined in the description, which group contains optionally multiple bonds or heteroatomes, A represents a cyclic group, m is an integer from 0 to 7 inclusive, the group(s) R 4 is (are) as defined in the description, R 3 represents a group selected from hydrogen, alkyl, alkenyl, alkynyl, and the group of formula (II): in which p, Z 2 , B, q, and R 13 are as defined in the description, optionally, its racemic forms, isomers thereof, N-oxydes thereof, and its the pharmaceutically acceptable salts thereof, and medicinal products containing the same are useful as specific inhibitors of tpe-13 matrix mettaloprotease.
    • 选自式(I)的化合物:其中:W表示N或C-R 1; 其中R1如说明书中所定义,X表示N或C-R2,其中R2如说明书中所定义,Y表示选自氧,硫,-NH和-N烷基的基团,Z表示选自 氧,硫,-NR 8,其中R8如说明书中所定义,可选地取决于Y的定义,n为0至8的整数,其中Z 1为基团-CR 9 R 10,其中R 9和R 10如 描述,该组包含任选的多个键或杂原子,A表示环状基团,m是0至7的整数,包括端值,其中R 4是如在说明书中所定义的(是),R 3表示选自 氢,烷基,烯基,炔基和式(II)基团:其中p,Z2,B,q和R13如说明书中所定义,任选地,其外消旋形式,异构体,N-氧化物, 及其药学上可接受的盐和含有它们的药用产品可用作特定的物质 tpe-13基质蛋白酶的抑制剂。
    • 3. 发明申请
    • AZABENZODIAZEPINES AS PHOSPHODIESTERASE-4 INHIBITORS
    • AZABENZODIAZEPINES作为磷酸二酯酶-4抑制剂
    • WO2005040168A1
    • 2005-05-06
    • PCT/IB2004/003406
    • 2004-10-18
    • WARNER-LAMBERT COMPANY LLCDEVILLERS, IngridGAUDILLIERE, BernardJACOBELLI, HenryPEVET, Isabelle
    • DEVILLERS, IngridGAUDILLIERE, BernardJACOBELLI, HenryPEVET, Isabelle
    • C07D471/16
    • C07D471/16
    • Compounds of formula (I): characterized in that: • R l represents a group selected from hydrogen atom, methyl, methoxy, hydroxy, amino, dimethylamino, acetamido, pyrrolidin-l-yl, and hydroxymethyl; • R 2 represent a group selected from phenyl, pyridyl, pyrimidyl, quinolyl, isoquinolyl, indolyl, pyrolyl, [1,2,3]-triazolyl, benzo[c]isoxazolyl, thienyl, pyrazolyl, isothiazolyl, imidazolyl, benzofuranyl, pyrazolo[5,1-c][1,2,4]triazyl each of these groups being optionally substituted from 1 to 3 groups, identical or different independently of each other, selected from halogen, trifluoromethyl, (C1-C4)alkyl, (C I -C4)alkoxy, hydroxy, amino, acetamido, tert-butyloxycarbonylamino, cycloalkylcarbonylamino, sulfonamide, nitro, acetylmethoxy, cyclopentyloxy; optionally, their optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and their use as active ingredient in pharmaceutical composition useful for treating diseases involving therapy by inhibition of PDE4.
    • 式(I)的化合物:其特征在于: R 1表示选自氢原子,甲基,甲氧基,羟基,氨基,二甲基氨基,乙酰氨基,吡咯烷-1-基和羟甲基的基团。 。 R2代表选自苯基,吡啶基,嘧啶基,喹啉基,异喹啉基,吲哚基,焦油基,[1,2,3]三唑基,苯并[c]异恶唑基,噻吩基,吡唑基,异噻唑基,咪唑基,苯并呋喃基,吡唑并[ 1-c] [1,2,4]三氮烷,这些基团各自任选被1至3个彼此相同或不同的基团取代,所述基团选自卤素,三氟甲基,(C 1 -C 4)烷基,(C 1 -C 4) )烷氧基,羟基,氨基,乙酰氨基,叔丁氧基羰基氨基,环烷基羰基氨基,磺酰胺,硝基,乙酰基甲氧基,环戊氧基; 任选的它们的光学异构体及其与药学上可接受的酸或碱的加成盐,以及它们作为药物组合物的有效成分的用途,可用于治疗涉及通过抑制PDE4治疗的疾病。
    • 4. 发明申请
    • OXO-AZABICYCLIC COMPOUNDS
    • OXO-AZABICYCLIC化合物
    • WO2003076417A2
    • 2003-09-18
    • PCT/EP2003/002277
    • 2003-03-06
    • WARNER-LAMBERT COMPANY LLCGAUDILLIERE, BernardJACOBELLI, HenryKOSTLAN, CatherineLI, JackYUE, Wen-Song
    • GAUDILLIERE, BernardJACOBELLI, HenryKOSTLAN, CatherineLI, JackYUE, Wen-Song
    • C07D239/91
    • C07D471/04C07D239/91
    • A compound selected from those of formula (1): ~',Xi Gi X 2 (7l) I ,N - R 1 (I) 11 - G 2 X3 wherein: 5 • X,, X2, and X3, represent N or -CR3 in which R3 is as described in the description, • G, represents a group selected from those of formulae (i/a) and (i/b): R4 R6 \ R4 N (i/a) (i/b) in which R4, R5, and R6 are as defined in the description, • G2 represents a group selected from carbon-carbon triple bond, -CH=C=CH-, C=O, 10 C=S, S(O) n , in which nl represents an integer from 0 to 2 inclusive, or a group of formula (i/c): 11-1y -r ( i/c ) Y 1 in which Y1 represents O, S, -NH or -Nalkyl, and Y2 represents O, S, -NH or -Nalkyl, • n is an integer from 0 to 6 inclusive, and m is an integer from 0 to 7 inclusive, 15 • Z, represents -CRgR,o, wherein R9 and R I O areas defined in the description, • A represents a ring system, • R, represents a group selected from H, alkyl, alkenyl, alkynyl, optionally substituted and the group of formula (i/d) (G3)q~(Z2 )~ (i/d) 20 in which p, Z2, B, q and G3 are as defined in the description and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.
    • 选自式(I)的化合物的化合物,其中:X 1,X 2和X 3表示N或-CR 3,其中R 3如描述中所述,G 1表示选自式(i / a)和( 其中R 4,R 5和R 6如说明书中所定义,R 2表示选自碳 - 碳三键,-CH = C = CH-,C = O,C = S,S(O )n1,其中n1表示0〜2的整数,或其中Y1表示O,S,-NH或-N烷基的式(i / c)基团,Y2表示O,S,-NH或-N烷基 n为0以上6以下的整数,m为0以上7以下的整数,Z1为-CR9R10,其中,R9和R10如说明书中所定义,A表示环系,R1表示选自 H,烷基,烯基,炔基,任选被取代的基团和其中p,Z2,B,q和G3如说明书中所定义的任选的其光学异构体,N-氧化物和加成 其盐与药学上可接受的 le酸或碱,含有它们的药物可用作13型基质金属蛋白酶的特异性抑制剂。
    • 5. 发明申请
    • OXO AZABICYCLIC COMPOUNDS
    • OXO AZABICYCLIC化合物
    • WO2003076416A1
    • 2003-09-18
    • PCT/EP2002/003240
    • 2002-03-08
    • WARNER-LAMBERT COMPANY LLCGAUDILLIERE, BernardJACOBELLI, HenryKOSTLAN, CatherineLI, JackYUE, Wen-Song
    • GAUDILLIERE, BernardJACOBELLI, HenryKOSTLAN, CatherineLI, JackYUE, Wen-Song
    • C07D239/91
    • C07D471/04C07D239/91
    • A compound selected from those of formula (I): formula (I) wherein: - X 1 , X 2 , and X 3 , represent N or CR 3 in which R 3 is as described in the description, - G 1 represents a group selected from those of formulae (i/a) and (i/b): formula (II) in which R 4 , R 5 , and R 6 are as defined in the description, - G 2 represents a group selected from carbon-carbon triple bond, -CH=C=CH-, C=O, C=S, S(O) nt in which n1 represents an integer from 0 to 2 inclusive, or a group of formula (i/c): formula (III) in which Y 1 represents O, S, -NH or Nalkyl, and Y 2 represents O, S, -NH or Nalkyl, - n is an integer from 0 to 6 inclusive, and m is an integer from 0 to 7 inclusive, Z 1 represents CR 9 R 10 , wherein R 9 and R 10 are as defined in the description, - A represents a ring system, - R 1 represents a group selected from H, alkyl, alkenyl, alkynyl, optionally substituted and the group of formula (i/d): formula (IV) in which p, Z 2 , B, q and G 3 are as defined in the description and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.
    • 选自式(I)的化合物:式(I)其中:-X 1,X 2和X 3表示其中R 3如描述中所述的N或CR 3,-G1表示选自式 I / a)和(i / b):其中R 4,R 5和R 6如说明书中所定义的式(II),-G2表示选自碳 - 碳三键,-CH = C = CH- ,C = O,C = S,S(O)nt,其中n1表示0〜2的整数,或式(i / c):式(III)的基团,其中Y1表示O,S, NH或N烷基,Y2表示O,S,-NH或N烷基,-n为0〜6的整数,m为0〜7的整数,Z1表示CR9R10,其中R9和R10如 描述,-A表示环系,-R 1表示选自H,烷基,烯基,炔基,任选取代的基团和式(I / d)的基团:式(IV)其中p,Z2,B, q和G3如说明书中所定义,并且任选地,其光学异构体, 和其药学上可接受的酸或碱的加成盐和含有它们的药物可用作13型基质金属蛋白酶的特异性抑制剂。
    • 6. 发明申请
    • THIAZINE AND OXAZINE DERIVATIVES AS MMP-13 INHIBITORS FOR TREATING ARTHRITIS
    • 作为治疗ARTHRITIS的MMP-13抑制剂的噻嗪和氧化衍生物
    • WO2004000322A1
    • 2003-12-31
    • PCT/EP2003/006601
    • 2003-06-24
    • WARNER-LAMBERT COMPANY LLCGAUDILLIERE, BernardJACOBELLI, Henry
    • GAUDILLIERE, BernardJACOBELLI, Henry
    • A61K31/536
    • C07D265/26C07D279/08
    • A compound selected from those of formula (I): wherein: • X 1 , X 2 , and X 3 represent nitrogen or -CR 3 in which R 3 represents hydrogen, alkyl, amino, alkylamino, dialkylamino, hydroxy, alkoxy, or halogen, • G l represents oxygen or S(O) p in which p is from 0 to 2, • G 2 represents carbon-carbon triple bond, C=O, C=S, S(O) q in which q is from 0 to 2, or a group of formula (i/a): in which Y I and Y 2 are as defined in the description, • n is fromO to 6, Z l represents -CR 4 R 5 , wherein R 4 and R 5 are as defined in the description, • A represents 5- or 6-membered monocycle or bicycle aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, • R I represents hydrogen, alkyl, alkenyl, alkynyl, (these groups may be optionally substituted as defined in the description) or the group of formula (i/b): in which s, Z 2 , B, t and G 3 are as defined in the description, and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix metalloprotease, for the treatment of i.a arthritis and cancer.
    • 选自式(I)的化合物:其中: X 1,X 2和X 3表示氮或-CR 3,其中R 3表示氢,烷基,氨基,烷基氨基,二烷基氨基,羟基,烷氧基或卤素。 G 1表示氧或S(O)p,其中p为0至2。 G2表示碳 - 碳三键,C = O,C = S,其中q为0至2的S(O)q,或式(i / a)的基团:其中YI和Y2如 说明, 。 n为0至6,Z 1表示-CR 4 R 5,其中R 4和R 5如说明书中所定义。 A表示5-或6-元单环或自由基芳基,杂芳基,环烷基或杂环烷基。 R 1表示氢,烷基,烯基,炔基(这些基团可以如说明书中所定义的任意取代)或式(i / b)的基团:其中s,Z2,B,t和G3如 描述和任选的其光学异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作13型基质金属蛋白酶的特异性抑制剂,用于治疗ia关节炎 和癌症。
    • 9. 发明申请
    • NEW ALKYNYLATED QUINAZOLIN COMPOUNDS AS MMP-13 INHIBITORS
    • 新的烷基喹唑啉化合物作为MMP-13抑制剂
    • WO2004007469A1
    • 2004-01-22
    • PCT/EP2002/008475
    • 2002-07-12
    • WARNER-LAMBERT COMPANY LLCGAUDILLIERE, BernardJACOBELLI, HenryWILSON, Michael, WilliamPICARD, Joseph, Armand
    • GAUDILLIERE, BernardJACOBELLI, HenryWILSON, Michael, WilliamPICARD, Joseph, Armand
    • C07D239/96
    • C07D231/12C07D233/56C07D239/96C07D249/08C07D403/06C07D471/04C07D487/04C07F7/1856
    • A compound selected from those of formula (I) wherein W¿1? represents O, S, or -NR¿3? in which R¿3? represents hydrogen, alkyl, OH or CN; W¿2? represents a group selected from hydrogen, CF¿3?, NH¿2?, monoalkylamino, dialkylamino, alkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkylalkyl, heterocycle, these groups being optionally substituted, or W¿1? and W¿2? form together a group of formula -N=X¿4?-W¿3?- as defined in the description, X¿1?, X¿2? and X¿3? represent N or C optionally substituted, n is 0 to 8, Z represents -CR¿12?R¿13?, wherein R¿12? and R¿13? are as defined in the description, A represents a ring system, the groups R¿2? represent hydrogen or various chemical groups as defined in the description, q is 0 to 7; R¿1? represents hydrogen, alkyl, alkenyl, alkynyl, or a ring system, and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix metalloprotease.
    • 选自式(I)的化合物,其中W 1表示O,S或-NR 3, 其中R?3? 表示氢,烷基,OH或CN; W¿2? 表示选自氢,CF 3,NH 2,单烷基氨基,二烷基氨基,烷基,烯基,炔基,芳基,芳烷基,环烷基烷基,杂环,这些基团任选取代的基团,或W 1 和W?2? 形成一组式-N = X-4'-W 3' - 如说明书中所定义的X 1,X 2, 和X?3? 表示N或C任选取代,n为0至8,Z表示-CR 12 R 13,其中R 12, 和R ?? 13? 如在描述中所定义的,A代表一个环系,R = 表示如描述中定义的氢或各种化学基团,q为0至7; R¿1? 代表氢,烷基,烯基,炔基或环系,并且任选地,其光学异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作特异性抑制剂 13型基质金属蛋白酶。
    • 10. 发明申请
    • THIAZINE AND OXAZINE DERIVATIVES AS MMP-13 INHIBITORS FOR TREATING ARTHRITIS
    • 作为治疗ARTHRITIS的MMP-13抑制剂的噻嗪和氧化衍生物
    • WO2004000321A1
    • 2003-12-31
    • PCT/EP2002/008062
    • 2002-06-25
    • WARNER-LAMBERT COMPANY LLCGAUDILLIERE, BernardJACOBELLI, Henry
    • GAUDILLIERE, BernardJACOBELLI, Henry
    • A61K31/536
    • C07D265/26C07D279/08
    • A compound selected from those of formula (I) wherein: X 1 , X 2 and X 3 represent nitrogen or -CR 3 in which R 3 represents hydrogen, alkyl, amino, alkylamino, dialkylamino, hydroxy, alkoxy, or halogen, G 1 represents oxygen or S(O) p in which p is from 0 to 2, G 2 represents carbon-carbon triple bond, C=O, C=S, S(O) q in which q is from 0 to 2, or a group of formula (i/a) in which Y 1 and Y 2 are as defined in the description, n is from 0 to 6, Z 1 represents CR 4 R 5 . wherein R 4 and R 5 are as defined in the description, A represents 5- or 6-membered monocycle or bicycle aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, R 1 represents hydrogen, alkyl, alkenyl, alkynyl, (these groups may be optionally substituted as defined in the description) or the group of formula (i/b) in which s, Z 2 , B, t and G 3 are as defined in the description, and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix metalloprotease, for the treatment of i.a arthritis and cancer.
    • 选自式(I)的化合物,其中:X> 1 <,X> 2 <和X> 3代表氮或-CR 3,其中R 3表示氢,烷基,氨基,烷基氨基,二烷基氨基 ,羟基,烷氧基或卤素,G> 1 <代表氧或S(O)> p 2 <表示碳 - 碳三键,C = O,C = 其中q为0至2的S(O)q>或其中Y> 1 <和Y> 2 <如描述中所定义的式(i / a)的基团,n为0至6 ,Z> 1 4 <5>。 A表示5-或6-元单环或自由基芳基,杂芳基,环烷基或杂环烷基,R 1表示氢,烷基,烯基,炔基, (这些基团可以如说明书中定义的任选取代)或其中s,Z> 2 <,B,T和G> 3 <如说明书中所定义的式(i / b)的基团, 其光学异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐和含有它们的药物可用作13型基质金属蛋白酶的特异性抑制剂,用于治疗关节炎和癌症。